The Influence of Vitamin A Supplementation on Foxp3 and TGF-β Gene Expression in Atherosclerotic Patients

Journal of Nutrigenetics and Nutrigenomics

Volumn 5, Issue 6, 2013, Pages 314-326

  Mottaghi, Azadeh ^b   Salehi, Eisa ^c   Keshvarz, Ali ^b   Sezavar, Hashem ^d   Saboor Yaraghi, Ali Akbar ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b School of Public Health   (Iran)

^c Faculty of Medicine   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerosis; Foxp3; Gene expression; TGF

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; PHYTOHEMAGGLUTININ; PLACEBO; RETINOL PALMITATE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NUTRIGENOMICS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; VITAMIN SUPPLEMENTATION;

EID: 84873040945     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000341916     Document Type: Article

References (40)

1. Meraji S, Abuja PM, Hayn M, Kostner GM, Morris R, Oraii S, Tatzber F, Wonisch W, Zechner R, Gey KF: Relationship between classic risk factors, plasma antioxidants and indicators of oxidant stress in angina pectoris (AP) in Tehran. Atherosclerosis 2000; 150:403-412.
2. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A: Cytokine network and T cell immunity in atherosclerosis. Semin Immu-nopathol 2009; 31: 23-33.
3. Gotsman I, Gupta R, Lichtman AH: The influence of the regulatory T lymphocytes on atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 2493-2495.
4. Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B, Kuchroo VK: Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 2008; 181: 2277-2284.
5. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, Yao R, Chen Y, Liao YH: The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127:89-97.
6. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A: Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 2006; 173:803-810.
7. Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH: Vitamin A metabolites induce gut-homing Foxp3+ regulatory T cel ls. J Immunol 2007; 179: 3724-3733.
8. George J: Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2008; 5: 531-540.
9. Fontenot JD, Gavin MA, Rudensky AY: Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4:330-336.
10. de Boer OJ, van der Meer JJ, Teeling P, van der Loos CM, van der Wal AC: Low numbers of Foxp3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2007; 2:e779.
11. Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z: Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006; 12:178-180.
12. Mallat Z, Ait-Oufella H, Tedgui A: Regulatory T cell responses: potential role in the control of atherosclerosis. Curr Opin Lipidol 2005; 16: 518-524.
13. Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J: Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27:893-900.
14. Mor A, Luboshits G, Planer D, Keren G, George J: Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 2006; 27:2530-2537.
15. Kim CH: Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol 2008; 2008:416910.
16. Maynard CL, Hatton RD, Helms WS, Oliver JR, Stephensen CB, Weaver CT: Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and IL10 genes in developing regulatory T cells. J Exp Med 2009; 206: 343-357.
17. Zunino SJ, Storms DH, Stephensen CB: Diets rich in polyphenols and vitamin A inhibit the development of type I autoimmune diabetes in nonobese diabetic mice. J Nutr 2007; 137:1216-1221.
18. Miyagawa N, Homma T, Kagechika H, Shudo K, Nagai H: Effect of synthetic retinoid, TAC-101, on experimental autoimmune disease. Pharmacology 2003; 67:21-31.
19. Rhee EJ, Nallamshetty S, Plutzky J: Retinoid metabolism and its effects on the vasculature. Biochim Biophys Acta 2011; 1821: 230-240.
20. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE: Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 1995; 154: 450-458.
21. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, O'Shea JJ: Retinoic acid inhibits Th17 polarization and enhances Foxp3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 2008; 111:1013-1020.
22. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H: Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260.
23. Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ: All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 2007; 204:1765-1774.
24. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007; 204:1775-1785.
25. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007; 204:1757-1764.
26. Schambach F, Schupp M, Lazar MA, Reiner SL: Activation of retinoic acid receptor-alpha favours regulatory T cell induction at t he expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 2007; 37: 2396-2399.
27. Bai A, Lu N, Guo Y, Liu Z, Chen J, Peng Z: All-trans retinoic acid down-regulates inf lammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 2009; 86: 959-969.
28. Kishi H, Kuroda E, Mishima HK, Yamashita U: Role of TGF-beta in the retinoic acid-induced inhibition of proliferation and melanin synthesis in chick retinal pigment epithelial cells in vitro. Cell Biol Int 2001; 25:1125-1129.
29. Uchida H, Kuroki M, Shitama T, Hayashi H, Kuroki M: Activation of TGF-beta1 through up-regulation of TSP-1 by retinoic acid in retinal pigment epithelial cel ls. Curr Eye Res 2008; 33: 199-203.
30. MacDonald IM, Pannu R, Kovithavongs K, Peters C, Tredget EE, Ghahary A: Effect of retinoic acid on expression of transforming grow t h factor-beta by retina l pigment epithelial cells in cu lture. Can J Ophtha lmol 1995; 30: 301-305.
31. Mallat Z, Gojova A, Marchiol-Fournigault C, Esposito B, Kamate C, Merval R, Fradelizi D, Tedgui A: Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ Res 2001; 89: 930-934.
32. Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ: Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler Thromb Vasc Biol 2002; 22:975-982.
33. Grainger DJ, Mosedale DE, Metcalfe JC, Bottinger EP: Dietary fat and reduced levels of TGFbeta1 act synergistically to promote activation of the vascular endothelium and formation of lipid lesions. J Cell Sci 2000; 113:2355-2361.
34. Jenuwein T, Allis CD: Translating the histone code. Science 2001; 293:1074-1080.
35. Wang X, Allen C, Ballow M: Retinoic acid enhances the production of IL-10 while reducing the synthesis of IL-12 and TNF-a lpha from LPS-stimu lated monocy tes/macrophages. J Clin Immunol 2007; 27: 193-200.
36. Wang T, Monte MM, Huang W, Boudinot P, Martin SA, Secombes CJ: Identification of two Foxp3 genes in rainbow trout (oncorhynchus mykiss) with differential induction patterns. Mol Immunol 2010; 47:2563-2574.
37. Matsuura E, Kobayashi K, Tabuchi M, Lopez LR: Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog Lipid Res 2006; 45:466-486.
38. Hansson GK, Libby P, Schonbeck U, Yan ZQ: Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91:281-291.
39. Fortun A, Khalil A, Gagne D, Douziech N, Kuntz C, Jay-Gerin JP, Dupuis G, Fulop T Jr: Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation. Atherosclerosis 2001; 156:11-21.
40. Caspar-Bauguil S, Saadawi M, Negre-Salvayre A, Thomsen M, Salvayre R, Benoist H: Mildly oxidized low-density lipoproteins suppress the proliferation of activated CD4+ T-lymphocytes and their interleukin 2 receptor expression in vitro. Biochem J 1998; 330:659-666.